Just One More Step…

Opening Recap Market Pulse: Canada’s TSX barely budged, save for a lone space-and-defence stock that ripped away from the pack, while a drone tech maker

Overview – FDA Rejection and Class Action Trigger Corcept Therapeutics (NASDAQ: CORT) is a commercial-stage biotech focused on drugs that modulate the hormone cortisol for

Opening Recap Market Pulse: Tech stocks drifted in mixed fashion as robotics and AI buzz offset midweek weakness, leaving investors caught between Fed caution and